Answers are grounded in this paper and cite their sources.
BACKGROUND AND AIMS: Gamma-Glutamyl-Transferase (GGT) is a key enzyme in amino acid transport and in glutathione metabolism, making it essential for the counteraction of cellular oxidative stress. Clinically, it has been widely used as a marker for liver dysfunction and alcohol consumption. In the general population, elevated GGT has been associated with adverse outcomes, although this association is relatively unspecific. Therefore, the objective of the study was to reveal the prognostic capabilities of GGT in patients with alcohol consumption. METHODS: We assessed the outcome of hospitalized patients with acute decompensation in alcohol-associated liver cirrhosis and compared the predictive ability of GGT in patients with active and inactive alcohol consumption. RESULTS: A total of 313 patients with alcohol-associated liver cirrhosis were included in the study, of which 95 patients had active alcohol consumption (aALD) and 218 were classified as inactive (iALD). In the aALD group, GGT-levels correlated negatively with the MELD 3.0, CLIF-C-OF-Score and CLIF-C-AD-Score. Low GGT was also an independent predictor of 14-day, 30-day, 90-day and 1-year mortality, respectively. Intriguingly, high risk patients (GGT < 118 U/L) had significantly higher 90-day mortality rates (32.5%) than low risk patients (GGT > 118 U/L, 1.8%). DISCUSSION: Low GGT might be a greatly underestimated prognostic marker for mortality in cirrhotic patients with ongoing alcohol consumption and could be used as an additional variable for better risk stratification and selection for liver transplantation in these patients.
No takes yet. Share an insight, caveat, or question.
Weiss et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: